ISHA members may place requests for participation in research surveys from colleagues and general public on a special 'Research page' in the ISHA website. For more details contact secretary@ishaindia.org.in.
Request Form for Obtaining Data from ISHA Members
(The filled form is to be mailed to secretary@ishaindia.org.in)
| Name / Designation of the Researcher | ISHA Membership No | E-Mail / Mobile No | Brief Information about the Study | Google Form Link | Last date to Submit Response |
|---|---|---|---|---|---|
| Gowri Arakere/ SLP | L11050621 | gowri.arakere@gmail.com 1-443-538-3001 | In the U.S., SLPD stands for Speech-Language Pathology Doctor degree, an alternative to a PhD research degree for practicing clinicians who want to further develop their clinical knowledge base, learn how to conduct clinical research, and prepare to assume clinical leadership positions. The SLPD is an advanced clinical practice degree that's different from the entry-level master's degree in speech-language pathology. Graduates of the program can work as master clinicians, clinical researchers, or university clinical faculty Current SLPD programs in the United States are mostly online and are accessible to full-time working clinicians. It can be a full time or part time academic program. The length of the SLPD program varies depending on the university that offers it. The benefits of attaining an SLPD can be several. To state a few, an individual with a clinical doctorate degree is prepared for and is able to take on leadership positions, teach at a university level, start a private practice, etc. Intention of this study: If a clinical Doctor of Speech-Language Pathology degree is offered in India, we would like to 1) determine the interest and willingness of the SLPs to attain the degree; and 2) survey Indian SLPs, both clinical and university practitioners, to determine if the SLPD degree could potentially provide a service in the practice of speech-language pathology in India. | https://docs.google.com/forms/d/e/1FAIpQLScSkHQWtspdKdCM5WveGlWr8fEMsbXdHrGCJG3MxEfuJ1NAHQ/viewform?usp=sharing&ouid=101572194715311879975 | 30-10-2025 |
| Mr. Sourav Kumar, M.Sc. Audiology Student, III Semester, AIISH, Mysuru | L2409435 | neoaudiologist@gmail.com | Challenges in Ecological Momentary Assessment of Hearing Difficulties among Hearing Aid Users: Insights from Audiologists-This study aims to explore the perspectives and practices of audiologists in India regarding hearing aid fitting and the use of Ecological Momentary Assessment (EMA) in assessing hearing difficulties. We seek to identify the knowledge, attitudes, and challenges faced by audiologists in implementing EMA, with the ultimate goal of contributing to evidence-based improvements in hearing aid practices. | https://docs.google.com/forms/d/e/1FAIpQLScngsuKmst3vY2t2an2E0rJzkYYtdvdlKdtDXXXEbUlEnzMLA/viewform?usp=header | 08-11-2025 |
| M Kusuma - Junior Research Fellow; and Dr. Swapna N - Professor of Speech Pathology | L21113866 | kusumamaheshslp@gmail.com / +918904207441 | Dear Speech Language Pathologists, We, Ms. M Kusuma and Dr. Swapna N are conducting a survey exploring knowledge and practices in autism and feeding. Your valuable responses help us in understanding current knowledge and practices in this specialised area. We kindly ask you to complete the survey which takes 2-3 minutes approximately, using the following link | https://forms.gle/d8wwhFVtpBFuEQvo8 | 01-11-2025 |
| James E. Saunders, MD Professor of Otology / Neurotology Geisel School of Medicine at Dartmouth Co-Chair Coalition for Global Hearing Health Dartmouth-Hitchcock Medical Center One Medical Center Drive Lebanon, NH 03756 | Not a member | Lauren Dillard at dillalau@musc.edu / James.E.Saunders@hitchcock.org | This survey is designed to gather data on the actual utilization of ototoxic medications (aminoglycoside and chemotherapy agents) in a variety of global healthcare settings. Although this data is critical to estimate the impact of these medications on hearing loss, we recognize that some of these questions relate to conditions and medications that you might not directly treat or prescribe. If necessary, we ask that you consult with treating physicians in your home institutions. Thank you for participating in this survey. | https://www.surveymonkey.com/r/9SKY6GS | 26-09-2025 |